These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33996659)

  • 1. The prevalence of attention deficit hyperactivity disorder in Iran: An updated systematic review.
    Hakim Shooshtari M; Shariati B; Kamalzadeh L; Naserbakht M; Tayefi B; Taban M
    Med J Islam Repub Iran; 2021; 35():8. PubMed ID: 33996659
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of Attention Deficit Hyperactivity Disorder in Iran: A systematic review.
    Shooshtary MH; Chimeh N; Najafi M; Mohamadi MR; Yousefi-Nouraie R; Rahimi-Mvaghar A
    Iran J Psychiatry; 2010; 5(3):88-92. PubMed ID: 22952498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.
    Catalá-López F; Ridao M; Núñez-Beltrán A; Gènova-Maleras R; Alonso-Arroyo A; Aleixandre-Benavent R; Catalá MA; Tabarés-Seisdedos R
    Syst Rev; 2019 Feb; 8(1):49. PubMed ID: 30744675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autistic spectrum disorder symptoms in children and adolescents with attention-deficit/hyperactivity disorder: a meta-analytical review.
    Hollingdale J; Woodhouse E; Young S; Fridman A; Mandy W
    Psychol Med; 2020 Oct; 50(13):2240-2253. PubMed ID: 31530292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of attention deficit/hyperactivity disorder among children and adolescents in China: a systematic review and meta-analysis.
    Wang T; Liu K; Li Z; Xu Y; Liu Y; Shi W; Chen L
    BMC Psychiatry; 2017 Jan; 17(1):32. PubMed ID: 28103833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents in Africa: a systematic review and meta-analysis.
    Ayano G; Yohannes K; Abraha M
    Ann Gen Psychiatry; 2020; 19():21. PubMed ID: 32190100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
    Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH
    CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Storm MRO; Pereira Ribeiro J; Skoog M; Groth C; Callesen HE; Schaug JP; Darling Rasmussen P; Huus CL; Zwi M; Kirubakaran R; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009885. PubMed ID: 36971690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of bone fractures among children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Seens H; Modarresi S; MacDermid JC; Walton DM; Grewal R
    BMC Pediatr; 2021 Aug; 21(1):354. PubMed ID: 34412606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
    Catalá-López F; Hutton B; Page MJ; Ridao M; Driver JA; Alonso-Arroyo A; Forés-Martos J; Macías Saint-Gerons D; Vieta E; Valencia A; Tabarés-Seisdedos R
    Syst Rev; 2017 Sep; 6(1):189. PubMed ID: 28915839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses.
    Ayano G; Demelash S; Gizachew Y; Tsegay L; Alati R
    J Affect Disord; 2023 Oct; 339():860-866. PubMed ID: 37495084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Thomas R; Sanders S; Doust J; Beller E; Glasziou P
    Pediatrics; 2015 Apr; 135(4):e994-1001. PubMed ID: 25733754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthreshold attention deficit hyperactivity in children and adolescents: a systematic review.
    Balázs J; Keresztény A
    Eur Child Adolesc Psychiatry; 2014 Jun; 23(6):393-408. PubMed ID: 24399038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of attention deficit hyperactivity disorder in adults: Umbrella review of evidence generated across the globe.
    Ayano G; Tsegay L; Gizachew Y; Necho M; Yohannes K; Abraha M; Demelash S; Anbesaw T; Alati R
    Psychiatry Res; 2023 Oct; 328():115449. PubMed ID: 37708807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals: A Systematic Review and Meta-analysis.
    Cénat JM; Blais-Rochette C; Morse C; Vandette MP; Noorishad PG; Kogan C; Ndengeyingoma A; Labelle PR
    JAMA Psychiatry; 2021 Jan; 78(1):21-28. PubMed ID: 32902608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis.
    Salari N; Ghasemi H; Abdoli N; Rahmani A; Shiri MH; Hashemian AH; Akbari H; Mohammadi M
    Ital J Pediatr; 2023 Apr; 49(1):48. PubMed ID: 37081447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.